When: Active Now

Where: Be Well Clinical Studies

Location: Lincoln, Nebraska and Round Rock, Texas

The study is enrolling adults who*:

  • Are 55 to 90 years of age.

  • Have Alzheimer’s disease.

  • Have been experiencing agitation for at least 4 weeks.

    *Additional criteria will apply. Participants must have a caregiver who is willing to attend study visits and help with certain study activities. Participation in the study lasts about 5.5 months with visits to the study site to receive the study drug and for health checks and tests.

 

BALANCE-AAD-1 Study

A clinical study for the treatment of agitation in adults with Alzheimer’s disease.

Agitation is one of the most common features of Alzheimer’s disease, occurring in up to 76% of people. It can cause a person to become restless, engage in repetitive behaviors such as rocking, or even become verbally or physically aggressive, such as shouting, pushing, or resisting, in certain places or situations. Agitation can significantly impact the quality of life for both the person with the condition and their caregivers.

Volunteer